Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and even if you’ve never heard of it before, there’s a very good ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

As flu and COVID season begins to hit New Mexico in force, health officials are encouraging people to get their vaccinations ...

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associated ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.

State officials are reminding Pennsylvanians to stay up-to-date on their annual vaccinations against respiratory diseases as ...

While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.